Universal Vision Biotechnology Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 1,028.46 million compared to TWD 835.6 million a year ago. Net income was TWD 266.02 million compared to TWD 213.34 million a year ago.

Basic earnings per share from continuing operations was TWD 3.1415 compared to TWD 2.5189 a year ago. Diluted earnings per share from continuing operations was TWD 3.1321 compared to TWD 2.5189 a year ago.